LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

MRK

116.3

+0.48%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

MRK

116.3

+0.48%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

MRK

116.3

+0.48%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

MRK

116.3

+0.48%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

MRK

116.3

+0.48%↑

Home・Akciju saraksts・Microbot Medical Inc

Microbot Medical Inc

Slēgts

2.51 -0.4

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

2.46

Max

2.56

Galvenie mērījumi
By Trading Economics
Ienākumi	-77K -3.6M
Darbinieki	20
EBITDA	-79K -3.6M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+197.62% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 30. marts

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	43M 183M
Iepriekšējā atvēršanas cena	2.91
Iepriekšējā slēgšanas cena	2.51

Tehniskais rādītājs

By Trading Central

Pārliecība

Neutral Evidence

2.52 / 2.57 Atbalsts un pretestība

Microbot Medical Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 24. marts 18:58 UTC

Galvenie tirgus virzītāji

MDA Space Shares Drop After NASA Shifts Focus to Moon's Surface and Away From Space Station

2026. g. 24. marts 23:48 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 24. marts 23:48 UTC

Tirgus saruna

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

2026. g. 24. marts 23:33 UTC

Tirgus saruna

Galvenie ziņu notikumi

Gold Rises, Boosted by Dollar Weakness -- Market Talk

2026. g. 24. marts 23:16 UTC

Tirgus saruna

Venezuelan Opposition Leader Says Oil Output Could Reach 5 Million B/D -- Market Talk

2026. g. 24. marts 22:40 UTC

Peļņas

Shanghai Fosun Pharmaceutical: Results Supported by Higher Rev From Innovative Drugs, Overseas Business >2196.HK

2026. g. 24. marts 22:40 UTC

Peļņas

Shanghai Fosun Pharmaceutical 2025 Net CNY3.37B Vs. Net CNY2.77B >2196.HK

2026. g. 24. marts 22:40 UTC

Peļņas

Shanghai Fosun Pharmaceutical 2025 Rev CNY41.50B Vs. CNY40.91B >2196.HK

2026. g. 24. marts 21:44 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 24. marts 21:44 UTC

Tirgus saruna

Sandfire's New Bull Excited by Kalkaroo Copper Deposit -- Market Talk

2026. g. 24. marts 20:59 UTC

Peļņas

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

2026. g. 24. marts 20:58 UTC

Galvenie ziņu notikumi

Israel Hits Russian-Iranian Weapons Smuggling Route in the Caspian Sea -- WSJ

2026. g. 24. marts 20:50 UTC

Tirgus saruna

Galvenie ziņu notikumi

Energy & Utilities Roundup: Market Talk

2026. g. 24. marts 20:50 UTC

Tirgus saruna

Galvenie ziņu notikumi

Basic Materials Roundup: Market Talk

2026. g. 24. marts 20:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 24. marts 20:25 UTC

Peļņas

This Palantir-Linked Drone Stock Was Flying Under the Radar -- Until Now -- Barrons.com

2026. g. 24. marts 20:15 UTC

Tirgus saruna

Galvenie ziņu notikumi

Global Commodities Roundup: Market Talk

2026. g. 24. marts 20:10 UTC

Tirgus saruna

Canada Mortgage Arrears Linked to Labor Market Performance -- Market Talk

2026. g. 24. marts 20:10 UTC

Peļņas

Worthington Enterprises 3Q Sales $378.7M >WOR

2026. g. 24. marts 20:10 UTC

Peļņas

Worthington Enterprises 3Q Adj EPS 98c >WOR

2026. g. 24. marts 20:10 UTC

Peļņas

Worthington Enterprises 3Q EPS 92c >WOR

2026. g. 24. marts 19:25 UTC

Tirgus saruna

Galvenie ziņu notikumi

Canada Needs Roughly 100 Days to Meet IEA's Oil-Stock Release -- Market Talk

2026. g. 24. marts 19:06 UTC

Tirgus saruna

Galvenie ziņu notikumi

Oil Futures Regain Ground As Strikes Continue in Middle East -- Market Talk

2026. g. 24. marts 18:51 UTC

Tirgus saruna

Galvenie ziņu notikumi

U.S. Natural Gas Settles Higher As Oil Futures Gain -- Market Talk

2026. g. 24. marts 18:40 UTC

Tirgus saruna

Galvenie ziņu notikumi

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 24. marts 18:40 UTC

Tirgus saruna

Galvenie ziņu notikumi

Mideast Conflict to Hobble But Not Derail Canadian Economy -- Market Talk

2026. g. 24. marts 18:34 UTC

Galvenie ziņu notikumi

Oil Production in the Middle East Will Take Months to Come Back, CEO says. Why $100 Oil Could Be Here to Stay. -- Barrons.com

2026. g. 24. marts 18:27 UTC

Tirgus saruna

Inflation Pickup Could Keep Bank of Mexico on Hold -- Market Talk

2026. g. 24. marts 18:21 UTC

Tirgus saruna

Galvenie ziņu notikumi

Silver Snaps 9-Session Losing Streak -- Market Talk

2026. g. 24. marts 18:00 UTC

Iegādes, apvienošanās, pārņemšana

Gilead to Buy Ouro Medicines for $2.2 Billion. Why the Deal Is Key to Future Stock Gains. -- Barrons.com

Salīdzinājums

Cenas izmaiņa

Microbot Medical Inc Prognoze

Cenas mērķis

By TipRanks

197.62% augšup

Prognoze 12 mēnešiem

Vidējais 7.5 USD 197.62%

Augstākais 12 USD

Zemākais 5 USD

Pamatojoties uz 3 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Microbot Medical Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

3 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 3 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Microbot Medical Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

2.52 / 2.57Atbalsts un pretestība

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.